A neuroprosthetic (also called as neural prosthetic) is any device that can enhance the input or output of a neural system. The most successful neuroprosthetic devices developed to date are cochlear implants for patients with hearing impairment, and prosthetic devices for amputees. Neuroprosthetics encompass a variety of artificial devices or systems that can be used to enhance the motor, sensory, cognitive, visual, auditory, and communicative deficits that arise from acquired brain injuries.
According to this analysis, the Global Neuroprosthetics Market was valued at ~US$ 5 billion in 2017. It is estimated to be ~US$ 8 billion in 2022 and is forecasted to reach a market size of ~US$ 15 billion, growing at a CAGR of ~12% owing to the rising demand from the manufacturing industry.
The increasing prevalence of neurological disorders is driving the growth of the market. Neuroprosthetics are used when other treatments are unable to cure a disease or condition. The adoption of neuroprosthetic technologies, such as SCS, DBS, Vagus nerve stimulation (VNS), and sacral cord stimulation, is growing in developed countries such as the US, Canada, and Australia, boosting the growth of the overall market.
The high cost of neuroprosthetic products is challenging the neuroprosthetics market growth. Cochlear implants are more expensive than hearing aids. The high cost of surgery and difficulty in maintenance is anticipated to pose a significant challenge during the forecast time. The high cost of the implants, as well as the problem of maintaining them, has hampered market growth.
The market was significantly impacted by the COVID-19 pandemic during the first half of 2020, due to a major drop in non-urgent treatments such as cochlear implant surgery around the world. With the increase in COVID-19 cases, governments around the world implemented various safety measures such as lockdowns and stringent guidelines, disrupting the international supply chain of cochlear implants.
By Technique: The spinal cord stimulation segment held the largest market share in the global neuroprosthetics market in 2021, due to the rising prevalence of chronic pain among the population across the globe.
The increasing failed back syndrome, and complex regional pain syndrome are projected to increase the demand for spinal cord stimulation technology-based neuroprosthetics devices.
The recent product approvals based on spinal cord stimulation technology is likely to propel the neuroprosthetics market in the coming future. For instance, in July 2021, Nevro received FDA approval for its 10 kHz high-frequency spinal cord stimulation therapy for the treatment of chronic pain associated with Painful Diabetic Neuropathy (PDN).
By Application: The motor neural prosthetics segment held the largest market share in the global Neuroprosthetics market in 2021, owing to its rising adoption in parkinson’s and epilepsy coupled with the rising prevalence of these aforementioned disorders.
Cognitive disorders segment is expected to hold the highest CAGR during the forecast period, owing to the rising incidences of Alzheimer’s disease and severe depression.
The introduction of advanced implants capable of calculating limb trajectory and stimulating motor control for movements, used in the treatment of paralysis are further anticipated to augment the market growth over the forecast period.
By Region: North Americaheld the largest market share among all other regions within the global neuroprosthetics market in 2021, due to the supporting government policies to augment the growth of the region.
The large share of the region is attributed to the presence of factors, such as government & private funding and well-established healthcare facilities.
In the USA, more than a thousand people are living with spinal cord injury and half of these people cannot move from the neck which is expected to drive the treatment through neuroprosthetics.
Country-niche players constitute ~25% of the total number of competitors, while regional players dominate representing ~45% of total competitors. Some of the major players in the market include Abbott, Boston Scientific Corporation, Cochlear Ltd, Cyberonics, Inc., LivaNova PLC, Medtronic, NeuroPace, Inc., BioRegio STERN Management GmbH, Second Sight, Sonova, among others.
Note: This is an On-Demand/Planned report, so the figures quoted here for market size estimate, forecast, growth, segment share, and competitive landscape are based on initial findings and might vary slightly in the actual report. Also, any required customizations can be covered to the best feasible extent for Pre-booking clients and report delivered within a maximum of 2 working weeks.
According to this analysis, the Global Neuroprosthetics Market was valued at ~US$ 5 billion in 2017. It is estimated to be ~US$ 8 billion in 2022 and is forecasted to reach a market size of ~US$ 15 billion, growing at a CAGR of ~12% owing to the rising demand from the manufacturing industry.
The increasing prevalence of neurological disorders is driving the growth of the market. Neuroprosthetics are used when other treatments are unable to cure a disease or condition. The adoption of neuroprosthetic technologies, such as SCS, DBS, Vagus nerve stimulation (VNS), and sacral cord stimulation, is growing in developed countries such as the US, Canada, and Australia, boosting the growth of the overall market.
The high cost of neuroprosthetic products is challenging the neuroprosthetics market growth. Cochlear implants are more expensive than hearing aids. The high cost of surgery and difficulty in maintenance is anticipated to pose a significant challenge during the forecast time. The high cost of the implants, as well as the problem of maintaining them, has hampered market growth.
The market was significantly impacted by the COVID-19 pandemic during the first half of 2020, due to a major drop in non-urgent treatments such as cochlear implant surgery around the world. With the increase in COVID-19 cases, governments around the world implemented various safety measures such as lockdowns and stringent guidelines, disrupting the international supply chain of cochlear implants.
Scope of the Report
The Neuroprosthetics market is segmented by type, technique, application, and region. In addition, the report also covers the market size for each of the four regions' Neuroprosthetics market. The revenue used to size and forecast the market for each segment is US$ billion.Type
- Output Neural Prosthetics
- Motor Prosthetics
- Cognitive Prosthetics
- Input Neural Prosthetics
- Cochlear Implants
- Bionic Eye/Retinal Implants
Technique
- Deep Brain Stimulation
- Vagus Nerve Stimulation
- Spinal Cord Stimulation
- Sacral Nerve Stimulation
Application
- Motor Neural Prosthetics
- Parkinson’s disease
- Epilepsy
- Physiological Disorders
- Auditory Processing Disorders
- Ophthalmic Disorders
- Cardiovascular Disorders
- Urology Disorders
- Cognitive Disorders
- Alzheimer’s Disease
- Paralysis
Region
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Spain, Italy, Rest of Europe)
- Asia Pacific (China, Japan, South Korea, India, Indonesia, Australia, Rest of Asia Pacific)
- LAMEA (Latin America, Middle East, Africa)
Key Players
- Abbott
- Boston Scientific Corporation
- Cochlear Ltd
- Cyberonics, Inc
- LivaNova PLC
- Medtronic
- NeuroPace, Inc
- BioRegio STERN Management GmbH
- Second Sight
- Sonova
Key Trends by Market Segment
- By Type: The input neural prosthetics segment held the largest market share in the global neuroprosthetics market in 2021, owing to the growing burden of hearing loss and advancements in technology for the development of novel devices
- The input neural prosthetics include a cochlear Implant and bionic eye/retinal Implant These are electronic devices that can help to provide a sense of sound to a person who is profoundly deaf or severely hard of hearing
By Technique: The spinal cord stimulation segment held the largest market share in the global neuroprosthetics market in 2021, due to the rising prevalence of chronic pain among the population across the globe.
The increasing failed back syndrome, and complex regional pain syndrome are projected to increase the demand for spinal cord stimulation technology-based neuroprosthetics devices.
The recent product approvals based on spinal cord stimulation technology is likely to propel the neuroprosthetics market in the coming future. For instance, in July 2021, Nevro received FDA approval for its 10 kHz high-frequency spinal cord stimulation therapy for the treatment of chronic pain associated with Painful Diabetic Neuropathy (PDN).
By Application: The motor neural prosthetics segment held the largest market share in the global Neuroprosthetics market in 2021, owing to its rising adoption in parkinson’s and epilepsy coupled with the rising prevalence of these aforementioned disorders.
Cognitive disorders segment is expected to hold the highest CAGR during the forecast period, owing to the rising incidences of Alzheimer’s disease and severe depression.
The introduction of advanced implants capable of calculating limb trajectory and stimulating motor control for movements, used in the treatment of paralysis are further anticipated to augment the market growth over the forecast period.
By Region: North Americaheld the largest market share among all other regions within the global neuroprosthetics market in 2021, due to the supporting government policies to augment the growth of the region.
The large share of the region is attributed to the presence of factors, such as government & private funding and well-established healthcare facilities.
In the USA, more than a thousand people are living with spinal cord injury and half of these people cannot move from the neck which is expected to drive the treatment through neuroprosthetics.
Competitive Landscape
The Global Neuroprosthetics Market is highly competitive with ~150 players, including globally diversified players, regional players, and many country-niche players. Most of the regional players are the developers of Neuroprosthetics used in various end-user industries.Country-niche players constitute ~25% of the total number of competitors, while regional players dominate representing ~45% of total competitors. Some of the major players in the market include Abbott, Boston Scientific Corporation, Cochlear Ltd, Cyberonics, Inc., LivaNova PLC, Medtronic, NeuroPace, Inc., BioRegio STERN Management GmbH, Second Sight, Sonova, among others.
Recent Developments Related to Major Players and Organizations
- In July 2022, Sensorion declared that regulatory authorities in Australia have given their approval for the start of a Proof of Concept (POC) clinical trial of SENS-401 (Arazasetron) in patients who are scheduled for cochlear implantation
- In January 2022, TODOC, a Korean company that specializes in neural prosthesis and neuromodulation systems, announced the introduction of its artificial cochlear implant 'SULLIVAN' at the 'CES 2022' in Las Vegas
Conclusion
The Global Neuroprosthetics Market witnessed a negative impact due to COVID-19 owing to the strict regulations in several countries that temporarily halted all types of processes and shut down all the major industries. Input Neural Prosthetics, which include cochlear implants and bionic eye/retinal implants are the most common type of neuroprosthetics. Majorly, the spinal cord stimulation neuroprosthetics technique is used for treating cognitive disorders such as Alzheimer’s disease and paralysis. Though the market is competitive with over ~150 participants, regional players control the dominant share in the market and country-niche players also hold a significant share.Note: This is an On-Demand/Planned report, so the figures quoted here for market size estimate, forecast, growth, segment share, and competitive landscape are based on initial findings and might vary slightly in the actual report. Also, any required customizations can be covered to the best feasible extent for Pre-booking clients and report delivered within a maximum of 2 working weeks.
Key Topics Covered in the Report
- Snapshot of Global Neuroprosthetics Market
- Industry Value Chain and Ecosystem Analysis
- Market size and Segmentation of the Global Neuroprosthetics Market
- Historic Growth of Overall Global Neuroprosthetics Market and Segments
- Competition Scenario of the Market and Key Developments of Competitors
- Porter’s 5 Forces Analysis of Global Neuroprosthetics Industry
- Overview, Product Offerings, Strengths, & Weaknesses of Key Competitors
- Covid-19 Impact on the Overall Global Neuroprosthetics Market
- Future Market Forecast and Growth Rates of the Global Neuroprosthetics Market and Segments
- Analysis of Global Neuroprosthetics Market
- Major Production/Supply and Consumption/Demand Hubs within Each Region
- Major Country-wise Historic and Future Market Growth Rates of the Total Market and Segments
- Overview of Notable Emerging Competitor Companies within Each Region
Notable Key Players Mentioned in the Report
- Abbott
- Boston Scientific Corporation
- Cochlear Ltd
- Cyberonics, Inc
- LivaNova PLC
- Medtronic
- NeuroPace, Inc
- BioRegio STERN Management GmbH
- Second Sight
- SoNV
- iotaMotion, Inc
- Hemideina
- TODOC Co, Ltd
- ADVANCED OPTRONICS
- Restohearing
Key Target Audience - Organizations and Entities Who Can Benefit by Subscribing This Report
- Neuroprosthetics Manufacturers
- Neuroprosthetics Suppliers
- Output Neural Prosthetics Manufacturers
- Input Neural Prosthetics Manufacturers
- Deep Brain Stimulation Neuroprosthetics Manufacturers
- Vagus Nerve Stimulation Neuroprosthetics Manufacturers
- Spinal Cord Stimulation Neuroprosthetics Manufacturers
- Sacral Nerve Stimulation Neuroprosthetics Manufacturers
- Emerging and Startup Companies in Neuroprosthetics
- Different Types of Neuroprosthetics Manufacturing Hubs
- Government Ministries and Departments of Healthcare Industry
- Healthcare Regulatory Organizations
- Healthcare Research Institutes
- Importers and Distributors of Neuroprosthetics
- Financial Organizations focused on Healthcare Industry
- PE and VC Firms focused on Healthcare Industry
Period Captured in the Report
- Historical Period: 2017-2021
- Forecast Period: 2022E-2028F
Frequently Asked Questions
What is the Study Period of this Market Report?- The Global Neuroprosthetics Market is covered from 2017-2028 in this report, which includes a forecast for the period (2022-2028)
- The global neuroprosthetics market is expected to witness a CAGR of ~12% over the next 6 years
- The rising prevalence of hearing disorders is one of the primary drivers for the growth of the global neuroprosthetics market
- The cognitive disorders segment held the largest share of the global neuroprosthetics market in 2021
- Abbott, Boston Scientific Corporation, Cochlear Ltd, Cyberonics, Inc., LivaNova PLC, Medtronic, NeuroPace, Inc.., BioRegio STERN Management GmbH, Second Sight, Sonova, among others are the major companies operating in Global neuroprosthetics Market
Additional benefits of purchasing an enterprise license:
- TAM/SAM/SOM Analysis
- Customer Cohort Analysis
- Marketing Initiatives
- White Space Opportunity Analysis
- Interactive Data Visualizations
- Customization: 20 Analyst Hours
- 3 Months Post Sales Analyst Support
- Complimentary Update Next Year
- Custom Webinars
Table of Contents
1. Executive Summary
2. Market Overview and Key Trends Impacting Growth
3. Global - Market Segmentation by Type, Historic Growth, Outlook & Forecasts
4. Global - Market Segmentation by Technique, Historic Growth, Outlook & Forecasts
5. Global - Market Segmentation by Application, Historic Growth, Outlook & Forecasts
6. Industry/Competition Analysis - Competitive Landscape
7. Key Competitor Profiles (Company Overview, Product Offerings, and Strengths & Weaknesses Analysis)
8. Geographic Analysis & Major Countries Market Historic Growth, Outlook, and Forecasts
9. Industry Expert’s Opinions/Perspectives
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott
- Boston Scientific Corporation
- Cochlear Ltd
- Cyberonics, Inc.
- LivaNova PLC
- Medtronic
- NeuroPace, Inc..
- BioRegio STERN Management GmbH
- Second Sight
- Sonova
- iotaMotion, Inc.
- Hemideina
- TODOC Co., Ltd.
- ADVANCED OPTRONICS
- Restohearing
